Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone

Journal of Cellular Biochemistry

Volumn 76, Issue 2, 2000, Pages 231-243

  Dieudonné, Suzanne C ^a   Kerr, Janet M ^a   Xu, Tianshun ^a   Sommer, Beatrice ^a   DeRubeis, Anna R ^a   Kuznetsov, Sergei A ^a   Kim, In San ^b   Robey, Pamela Gehron ^a   Young, Marian F ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b Kyungpook National University   (South Korea)

Author keywords

Dexamethasone; Differential display; Human bone marrow stroma; ig h3

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; MESSENGER RNA; MUSCLE PROTEIN; OSTEONECTIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; BONE MARROW; CONTROLLED STUDY; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL;

EID: 0033451485     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000201)76:2<231::AID-JCB7>3.0.CO;2-X     Document Type: Article

References (67)

1. Abildgaard N, Bendix-Hansen K, Kristensen JE, Vejlgaard T, Risteli L, Nielsen JL, Heickendorff L. 1997. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum. Br J Haematol 99:641-648.
2. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. 1980. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop 151:294-307.
3. Bamberger CM, Schulte HM, Chrousos GP. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17:245-261.
4. Bellows CG, Heersche JN, Aubin JE. 1990. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. DevBiol 140:132-138.
5. Bennett JH, Joyner CJ, Triffitt JT, Owen ME. 1991. Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-139.
6. Carey GB, Chang NS. 1998. Cloning and characterization of a transforming growth factor beta 1-induced anti-apoptotic adhesion protein TIF2. Biochem Biophys Res Commun 249:283-286.
7. Centrella M, Massague J, Canalis E. 1986. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119:2306-2312.
8. Cheng S-L, Zhang SF, Avioli LV. 1996. Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells. J Cell Biochem 61:182-193.
9. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA. 1998. Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int 62:74-82.
10. Delany A, Amling M, Priemel M, Delling G, Howe C, Baron R, Canalis E. 1998. Osteonectin-null mice develop severe osteopenia. Bone 23:S199.
11. Faucheux C, Ulysse F, Bareille R, Reddi AH, Amedee J. 1997. Opposing actions of BMP3 and TGF beta 1 in human bone marrow stromal cell growth and differentiation. Biochem Biophys Res Commun 241:787-793.
12. Friedenstein AJ. 1990. Osteogenic stem cells in the bone marrow. Bone Miner Res 7:243-272.
13. Fromigue O, Marie PJ, Lomri A. 1997. Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9:613-623.
14. Gehron Robey P. 1989. The biochemistry of bone. In: Tiegs RA, editor. Endocrinology and metabolism clinics of North America. New York: W.B. Saunders. p 859-902.
15. Gehron Robey P, Boskey AL. 1996. The biochemistry of bone. San Diego: Academic Press.
16. 2+-binding proteins. J Biol Chem 265:4703-4710.
17. Gibson MA, Kumaratilake JS, Cleary EG. 1997. Immunohistochemical and ultrastructural localization of MP78/70 (βig-h3) in extracellular matrix of developing and mature bovine tissues. J Histochem Cytochem 45:1683-1696.
18. Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM, Thompson EW. 1998. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 58:5529-5536.
19. Gouveia CH, Jorgetti V, Bianco AC. 1997. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats. J Bone Miner Res 12:2098-2107.
20. Gronowicz GA, DeRome ME, McCarthy MB. 1991. Glucocorticoids inhibit fibronectin synthesis and messenger ribonucleic acid levels in cultured fetal rat parietal bones. Endocrinology 128:1107-1114.
21. Gutman A, Kornblihtt AR. 1987. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci USA 84:7179-7182.
22. Gygi SP, Rochon Y, Franza BR, Aebersold R. 1999. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730.
23. Hashimoto K, Noshiro M, Ohno S, Kawamoto T, Satakeda H, Akagawa Y, Nakashima K, Okimura A, Ishida H, Okamoto T, Pan H, Shen M, Yan W, Kato Y. 1997. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim Biophys Acta 1355:303-314.
24. Hirano K, Klintworth GK, Zhan Q, Bennett K, Cintron C. 1996. Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas. Curr Eye Res 15:965-972.
25. Hubank M, Schatz DG. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640-5648.
26. Ishikawa Y, Genge BR, Wuthier RE, Wu LN. 1998. Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes. J Bone Miner Res 13:1398-1411.
27. Iwasaki A, Suda M, Watanabe M, Nakao H, Hattori Y, Nagoya T, Saino Y, Shidara Y, Maki M. 1989. Structure and expression of cDNA for calphobindin II, a human placental coagulation inhibitor. J Biochem (Tokyo) 106:43-49.
28. Kato H, Fukuda T, Parkison C, McPhie P, Cheng SY. 1989. Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase [published erratum appears in Proc Natl Acad Sci USA 1990 Feb;87(4):1625]. Proc Natl Acad Sc USA 6:7861-7865.
29. Kim J-E, Kim E-H, Han E-H, Park R-W, Park I-H, Jun S-H, Kim J-C, Young MF, Kim I-S. A TGF-β-inducible cell adhesion molecule, βig-h3 is downregulated in melorheostosis and involved in osteogenesis. J Cell Biochem in press.
30. Kimoto S, Cheng SL, Zhang SF, Avioli LV. 1994. The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells. Endocrinology 135:2423-2431.
31. Kutzsetsov SA, Grosheva AG, Friedenstein AJ. 1989. Osteogenic properties of adhesive cells from mouse bone marrow dexter treated cultures. Biull Eksp Biol Med 108:236-238.
32. Lees-Miller JP, Heeley DH, Smillie LB. 1987. An abundant and novel protein of 22 kDa (SM22) is widely distributed in smooth muscles. Purification from bovine aorta. Biochem J 244:705-709.
33. Lisitsyn N, Wigler M. 1993. Cloning the differences between two complex genomes. Science 259:946-951.
34. Mankoo BS, Dalgleish R. 1988. Human pro alpha 1(III) collagen: cDNA sequence for the 3' end. Nucleic Acids Res 16:2337.
35. Massague J. 1990. The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641.
36. Milne M, Kang MI, Quail JM, Baran DT. 1998. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures. Endocrinology 139:2527-2534.
37. Motamed K, Sage EH. 1998. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem 70: 543-552.
38. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK. 1996. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109:1369-1380.
39. Moursi AM, Globus RK, Damsky CH. 1997. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 110:2187-2196.
40. Munier FL, Korvatska E, Djemai A, Le Paslier D, Zografos L, Pescia G, Schorderet DF. 1997. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies [see comments]. Nature Genet 15:247-251.
41. Murano S, Thweatt R, Shmookler Reis RJ, Jones RA, Moerman EJ, Goldstein S. 1991. Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence. Mol Cell Biol 11: 3905-3914.
42. Owen M. 1988. Marrow stromal stem cells. J Cell Sci 10(suppl):63-76.
43. Patt HM, Maloney MA, Flannery ML. 1982. Hematopoietic microenvironment transfer by stromal fibroblasts derived from bone marrow varying in cellularity. Exp Hematol 10:738-742.
44. Perkinson RA, Kuo BA, Norton PA. 1996. Modulation of transcription of the rat fibronectin gene by cell density. J Cell Biochem 63:74-85.
45. Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. 1998. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem 71:55-62.
46. Potchinsky M, Nugent P, Lafferty C, Greene RM. 1996. Effects of dexamethasone on the expression of transforming growth factor-beta in mouse embryonic palatal mesenchymal cells. J Cell Physiol 166:380-386.
47. Rawe IM, Zhan Q, Burrows R, Bennett K, Cintron C. 1997. Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. Invest Ophthalmol Vis Sci 38:893-900.
48. Rozencwaig R, Wilson MR, McFarland GB Jr. 1997. Melorheostosis. Am J Orthop 26:83-89.
49. 2+-binding EF-hand sequence. J Cell Biochem 57:127-140.
50. Salomon DS, Pratt RM. 1979. Involvement of glucocorticoids in the development of the secondary palate. Differentiation 13:141-154.
51. Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knauper V, Murphy G, Timpl R. 1997. Limited cleavage of extracellular matrix protein BM-40 by matrix metallo-proteinases increases its affinity for collagens. J Biol Chem 272:9237-9243.
52. Schena M, Shalon D, Davis RW, Brown PO. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [see comments]. Science 270: 467-470.
53. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM. 1997. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173:327-334.
54. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H, Rodgers J, Purchio AF. 1994. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13:571-584.
55. Skonier J, Nerbauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. 1992. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocar-cinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 11:511-522.
56. Slavin J, Unemori E, Hunt TK, Amento E. 1994. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 11:205-213.
57. Sporn MB, Roberts AB. 1990. TGF-beta: problems and prospects. Cell Regul 1:875-882.
58. Suarez F, Rothhut B, Comera C, Touqui L, Marie FR, Silve C. 1993. Expression of annexin I, II, V, and VI by rat osteoblasts in primary culture: stimulation of annexin I expression by dexamethasone. J Bone Miner Res 8:1201-1210.
59. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. 1995. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23:4907-4912.
60. Suwanwalaikorn S, Van Auken M, Kang MI, Alex S, Braverman LE, Baran DT. 1997. Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization. Am J Physiol 272:E212-E217.
61. Swaroop A, Hogan BL, Francke U. 1988. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33. Genomics 2:37-47.
62. Thweatt R, Lumpkin CK Jr, Goldstein S. 1992. A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts. Biochem Biophys Res Commun 187:1-7.
63. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. 1995. Serial analysis of gene expression [see comments]. Science 270:484-487.
64. Wu LN, Genge BR, Lloyd GC, Wuthier RE. 1991. Collagen-binding proteins in collagenase-released matrix vesicles from cartilage. Interaction between matrix vesicle proteins and different types of collagen. J Biol Chem 266:1195-1203.
65. Young MF, Ibaraki K, Kerr JM, Heegaard A-M. 1993. Molecular and cellular biology of the major noncollagenous proteins in bone. San Diego, CA: Academic Press.
66. Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG. 1992. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop 281:275-294.
67. Yu YM, Becvar R, Yamada Y, Reddi AH. 1991. Changes in the gene expression of collagens, fibronectin, integrin and proteoglycans during matrix-induced bone morphogenesis. Biochem Biophys Res Commun 177:427-432.